The fused in sarcoma (FUS) protein is a hallmark of neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)[16], in which phosphorylation of FUS impairs its aggregation tendency and prion-like characteristics. Here, FUS is linked to amyotrophic lateral sclerosis.